Therapeutic Approach to Evans Syndrome in Pregnancy: A Case Series
DOI:
https://doi.org/10.33651/ptm.v9i1.804Keywords:
Evan Syndrome, pregnancy, therapeutic approach, case seriesAbstract
Background: Evans syndrome (ES) is a rare autoimmune disorder characterized by the combination of autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP), occasionally accompanied by autoimmune neutropenia. While it affects both children and adults, it shows a higher prevalence in adult females. The occurrence of ES during pregnancy is exceptionally rare, and standard therapeutic guidelines for its management remain lacking. Objective: To evaluate therapeutic approaches and clinical outcomes in pregnant women with Evans syndrome through a case series and literature review. Methods: A literature review and case series evaluation were conducted, focusing on pregnant women with ES treated across several hospitals. Data were retrieved from electronic databases and supplemented by manual searches up to late 2018. Results: Six cases of pregnant women with ES were analyzed. First-line therapies comprised corticosteroids and intravenous immunoglobulin (IVIG), whereas second-line management utilized immunosuppressive agents such as rituximab and cyclosporine. Splenectomy was reserved for refractory cases. Primary complications included infections, venous thromboembolism, and fetal growth restriction. Multidisciplinary collaboration was vital in optimizing both maternal and perinatal outcomes. Conclusion: Evans syndrome in pregnancy presents significant diagnostic and therapeutic challenges due to its rarity. Treatment strategies must be tailored individually, balancing maternal and fetal safety within a multidisciplinary management framework. This case series serves as a valuable reference for establishing future clinical guidelines..

